|
MAT2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.557820E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.142200E-03 |
| Normal-vs-Stage2 |
2.142200E-01 |
| Normal-vs-Stage3 |
4.254200E-01 |
| Normal-vs-Stage4 |
1.139410E-01 |
| Stage1-vs-Stage2 |
5.857000E-01 |
| Stage1-vs-Stage3 |
7.399100E-04 |
| Stage1-vs-Stage4 |
1.958640E-04 |
| Stage2-vs-Stage3 |
7.052400E-02 |
| Stage2-vs-Stage4 |
2.942200E-02 |
| Stage3-vs-Stage4 |
4.347000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.563600E-01 |
| Normal-vs-AfricanAmerican |
5.312100E-02 |
| Normal-vs-Asian |
7.460200E-03 |
| Caucasian-vs-AfricanAmerican |
1.207560E-01 |
| Caucasian-vs-Asian |
1.513620E-01 |
| AfricanAmerican-vs-Asian |
4.356600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.894000E-01 |
| Normal-vs-Female |
1.561150E-04 |
| Male-vs-Female |
1.6532000000069E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.215600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.568180E-01 |
| Normal-vs-Age(61-80Yrs) |
1.714600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.432600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.704500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.696100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.186030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.426000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.044600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.781200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.810100E-02 |
| Normal-vs-Grade 2 |
4.590600E-04 |
| Normal-vs-Grade 3 |
6.891200E-01 |
| Normal-vs-Grade 4 |
7.763800E-04 |
| Grade 1-vs-Grade 2 |
3.139200E-01 |
| Grade 1-vs-Grade 3 |
1.798410E-02 |
| Grade 1-vs-Grade 4 |
8.23410000000413E-05 |
| Grade 2-vs-Grade 3 |
1.196950E-03 |
| Grade 2-vs-Grade 4 |
1.24870003226363E-09 |
| Grade 3-vs-Grade 4 |
2.965400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.35119999528288E-08 |
| Normal-vs-ccB subtype |
4.263700E-03 |
| ccA subtype-vs-ccB subtype |
1.62503344114384E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.626790E-01 |
| Normal-vs-N1 |
1.298030E-02 |
| N0-vs-N1 |
4.501500E-03 |
|
|
